Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Bristol-Myers Squibb's Pravachol cleared by FDA for new indication

July 12, 1996

First approval of SmithKline Beecham's ReQuip in U.K.

July 12, 1996

CEA-Scan cleared for market by FDA

July 12, 1996

New formulaton of Videx launched in Canada

July 12, 1996

Ketotifen shown effective in NSAID-induced ulcer model

July 5, 1996

New beclomethasone formulation cleared for marketing

July 5, 1996

New Iomeron formulation introduced in Japan

July 5, 1996

Low-dose lovastatin + niacin shows good efficacy and safety in patient study

July 5, 1996

Prosorba trial initiated in arthritis sufferers

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...